• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Industry Audit + Company of the Year 2008

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-09-01-2008
Volume 0
Issue 0

Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)

External Link - article-550197.pdf

Articles in this issue
Industry Audit + Company of the Year 2008
The New Code
i4-548226-1408670152557.gif
Publish or Perish
i4-548215-1408670183813.gif
How Do You Solve a Problem Like Manufacturing?
i2-548221-1408670165725.gif
Foreign Affairs
Tapping the Fount
i3-548220-1408670169496.gif
The M&A Numbers
i3-548219-1408670172284.gif
The Salesforce Software Shift
i1-548217-1408670178681.jpg
Attack of the Junk
i1_t-548224-1408670158362.gif
Unleash the Dragon 2
i2-548225-1408670156163.gif
Place Your Bets
The Orphan Opportunity
i1-548218-1408670175812.jpg
Considering Consumer Change: Q&A with Jim Joseph, Saatchi & Saatchi
Doing More With Less
Related Videos
Related Content
Chris Martin, Chief Commercial Officer, Verona Pharma.

Lessons Learned on the Art and Science of Product Commercialization

April 19th 2024
Article

Insight that can help smaller biotech companies prepare for commercialization in the world of big pharma.

Sandra Von Meier

Advancing Healthcare Solutions: Harnessing Collaborative Business Models for Oncology

April 18th 2024
Article

Unique approaches are needed to bring solutions to fighting cancer and bacterial-resistant infections.

Peter Stark

Redefining Commercial with Modern Data for Today’s Complex Therapies: Q&A with Peter Stark, Executive VP and General Manager of Veeva Compass

March 4th 2024
Article

Stark discusses how the ways that data is reshaping commercial strategies.

Dan Rizzo

Two-Way Communication Connects HCPs to Reps in the Moment of Need: Q&A with Dan Rizzo, Veeva Business Consulting

January 11th 2024
Article

HCPs are utilizing new ways of communicating with reps, according to new data.

Dr. Herb Lin, senior research scholar for cyber policy and security at the Center for International Security and Cooperation and Hank J. Holland Fellow in Cyber Policy and Security at the Hoover Institution at Stanford University.

With Most Fortune 500 Companies Unprepared for New SEC Cyber Regulations, What Should Their Board of Directors Do? A Q&A with Dr. Herb Lin, Senior Research Scholar for Cybersecurity at Stanford University

January 8th 2024
Article

As the use of emerging technologies such as generative artificial intelligence continues to grow to support the innovation goals of Fortune 500 companies, so too does the risk of cybersecurity breaches.

Image credit: Naphat | stock.adobe.com

'Faster, Please': Key Challenges in Chemicals and Materials R&D

January 2nd 2024
Article

Companies must address myriad challenges to improve upon issues such as data quality and transparency, process efficiency, and artificial intelligence/machine learning preparedness.